Tag: #Empagliflozin
-
Empagliflozin and Water Retention A Breakthrough in Type 2 Diabetes Management
Introduction: Managing type 2 diabetes mellitus (T2DM) involves addressing multiple metabolic complications, including kidney function and water balance. A recent study published in the Journal of Clinical Nephrology explores how empagliflozin (EMPA), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, influences water retention through prostaglandin E2 (PGE2) responses in the collecting duct (CD). This research sheds light…
Heighten Science Publications Inc. 